Barbara C. Kahl

8.2k total citations · 1 hit paper
101 papers, 6.0k citations indexed

About

Barbara C. Kahl is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara C. Kahl has authored 101 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 52 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara C. Kahl's work include Antimicrobial Resistance in Staphylococcus (56 papers), Bacterial biofilms and quorum sensing (46 papers) and Cystic Fibrosis Research Advances (27 papers). Barbara C. Kahl is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (56 papers), Bacterial biofilms and quorum sensing (46 papers) and Cystic Fibrosis Research Advances (27 papers). Barbara C. Kahl collaborates with scholars based in Germany, United States and Belgium. Barbara C. Kahl's co-authors include Georg Peters, Richard A. Proctor, Karsten Becker, Mathias Herrmann, Christof von Eiff, Peter J. McNamara, Bettina Löffler, Mathias Herrmann, Erik Harms and Hans Georg Koch and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Barbara C. Kahl

100 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections

2006 891 citations Richard A. Proctor, Barbara C. Kahl et al. profile →

Peers

Countries citing papers authored by Barbara C. Kahl

Since Specialization

Citations

This map shows the geographic impact of Barbara C. Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara C. Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara C. Kahl more than expected).

Fields of papers citing papers by Barbara C. Kahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara C. Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara C. Kahl. The network helps show where Barbara C. Kahl may publish in the future.

Co-authorship network of co-authors of Barbara C. Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara C. Kahl. A scholar is included among the top collaborators of Barbara C. Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara C. Kahl. Barbara C. Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis 2022 ·Frontiers in Microbiology ·Hussein Chalhoub, Stefanie Kampmeier, Barbara C. Kahl, Françoise Van Bambeke	9
2	Lethal Waterhouse–Friderichsen syndrome caused by Capnocytophaga canimorsus in an asplenic patient 2022 ·BMC Infectious Diseases ·(unknown), Jan-Sören Padberg, (unknown), Philipp Kümpers, (unknown), (unknown), Andreas Uekötter, Frieder Schaumburg, Barbara C. Kahl	3
3	Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formation 2021 ·Nature Communications ·Kira L. Tomlinson, Tania Wong Fok Lung, (unknown), Medini K. Annavajhala, Stanislaw J. Gabryszewski, Ryan A. Groves, Marija Drikic, Nancy Francoeur, Shwetha Hara Sridhar, Melissa Smith, Sara Khanal, Clemente J. Britto, Robert Sebra, Ian A. Lewis, Anne‐Catrin Uhlemann, Barbara C. Kahl, Alice Prince, (unknown)	94
4	Importance of superoxide dismutases A and M for protection ofStaphylococcus aureusin the oxidative stressful environment of cystic fibrosis airways 2020 ·Cellular Microbiology ·(unknown), Diego Chaves‐Moreno, Silke Niemann, Dietmar H. Pieper, Thomas J. Vogl, Johannes Roth, Barbara C. Kahl	18
5	Finding the relevance of antimicrobial stewardship for cystic fibrosis 2020 ·Journal of Cystic Fibrosis ·Jonathan D. Cogen, Barbara C. Kahl, Holly Maples, Susanna A. McColley, Jason A. Roberts, Kevin Winthrop, Andrew M. Morris, Alison Holmes, Patrick A. Flume, Donald R. VanDevanter, Valerie Waters, Marianne S. Muhlebach, J.S. Elborn, Lisa Saiman, Scott C. Bell	18
6	Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation 2020 ·Cell Metabolism ·Sebastián A. Riquelme, (unknown), Tania Wong Fok Lung, Blanche L. Fields, Danielle Ahn, David Chen, Carmen Lozano, Yolanda Sáenz, Anne‐Catrin Uhlemann, Barbara C. Kahl, Clemente J. Britto, Emily DiMango, (unknown)	132
7	Degraded neutrophil extracellular traps promote the growth of Actinobacillus pleuropneumoniae 2019 ·Cell Death and Disease ·Nicole de Buhr, (unknown), (unknown), (unknown), (unknown), Barbara C. Kahl, Karl-Heinz Waldmann, Peter Valentin‐Weigand, Isabel Hennig‐Pauka, Maren von Köckritz‐Blickwede	36
8	Male kidney allograft recipients at risk for urinary tract infection? 2017 ·PLoS ONE ·Gerold Thölking, (unknown), Thomas Vogl, Ulrich Dobrindt, Barbara C. Kahl, Marcus Brand, Hermann Pavenstädt, Barbara Suwelack, Raphael Koch, Stefan Reuter	7
9	Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients 2016 ·PLoS Pathogens ·(unknown), Johannes Birtel, (unknown), (unknown), Alexander Mellmann, (unknown), (unknown), Hirschhausen Nina, Claudia Neumann, Jean C. Lee, Friedrich Götz, Holger Rohde, (unknown), Peter Küster, Georg Peters, Barbara C. Kahl	38
10	High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations 2016 ·International Journal of Antimicrobial Agents ·Hussein Chalhoub, Yolanda Sáenz, Hector Rodriguez‐Villalobos, Olivier Denis, Barbara C. Kahl, Paul M. Tulkens, Françoise Van Bambeke	52
11	Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium 2015 ·Journal of Cystic Fibrosis ·Ludwig Sedlacek, Barbara Graf, C. Schwarz, (unknown), Shajan Peter, (unknown), Stephan N. Wagner, Markus Klotz, (unknown), Gerhard Haase, (unknown), Barbara C. Kahl, Sebastian Suerbaum, Michael Seibold, Kathrin Tintelnot	72
12	Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients—An unrecognized CF pathogen? 2014 ·International Journal of Medical Microbiology ·(unknown), Veronika Tchesnokova, Angelika Dübbers, Peter Küster, Georg Peters, Ulrich Dobrindt, Evgeni V. Sokurenko, Barbara C. Kahl	21
13	Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients 2013 ·Clinical Microbiology and Infection ·(unknown), Barbara C. Kahl, Hanne Vebert Olesen, Søren Jensen‐Fangel, Niels Nørskov‐Lauritsen	7
14	Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data 2013 ·Journal of Antimicrobial Chemotherapy ·(unknown), Sandrine Lemaire, Barbara C. Kahl, Karsten Becker, Richard A. Proctor, Olivier Denis, Paul M. Tulkens, Françoise Van Bambeke	140
15	Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation 2013 ·International Journal of Medical Microbiology ·Hirschhausen Nina, (unknown), Irene Bianconi, Alessandra Bragonzi, Johannes Birtel, Jean C. Lee, Angelika Dübbers, Peter Küster, (unknown), Georg Peters, Barbara C. Kahl	64
16	Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa 2013 ·BMC Infectious Diseases ·Abraham Alabi, (unknown), (unknown), Katrin Kösters, Michaëla A. M. Huson, Barbara C. Kahl, Georg Peters, Martin P. Grobusch, Saadou Issifou, Peter G. Kremsner, Frieder Schaumburg	70
17	Acapsular clinical Staphylococcus aureus isolates lack agr function 2013 ·Clinical Microbiology and Infection ·Julia Fischer, Jean C. Lee, Georg Peters, Barbara C. Kahl	15
18	Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils 2010 ·PLoS Pathogens ·Bettina Löffler, Muzaffar Hussain, Matthias Grundmeier, (unknown), Dirk Holzinger, (unknown), Johannes Roth, Barbara C. Kahl, Richard A. Proctor, Georg Peters	331
19	Persistent Infection with Small Colony Variant Strains of Staphylococcus aureus in Patients with Cystic Fibrosis 1998 ·The Journal of Infectious Diseases ·Barbara C. Kahl, Mathias Herrmann, Anne Schulze Everding, Hans Georg Koch, Karsten Becker, Erik Harms, Richard A. Proctor, Gregory A. Peters	285
20	CMV-DNA detection in parenchymatous organs in cases of SIDS 1995 ·International Journal of Legal Medicine ·Rossana Cecchi, Thomas Bajanowski, Barbara C. Kahl, Peter Wiegand	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact